Wright Medical Group, Inc. Highlights Recent Innovations at the American Academy of Orthopaedic Surgeons (AAOS) 2015 Annual M...
March 24 2015 - 4:00PM
Wright Medical Group, Inc. (Nasdaq:WMGI) today announced that it
will highlight recent innovations at the American Academy of
Orthopaedic Surgeons (AAOS) 2015 Annual Meeting taking place at the
Venetian/Sands EXPO in Las Vegas, Nevada from March 24-28, 2015.
Wright will feature its full range of foot and ankle
reconstructive solutions at exhibit booth #3425, including the
following products and recent innovations:
- INFINITY® Total Ankle Replacement (TAR) System
– The lower profile design and straightforward surgical approach of
the INFINITY® TAR system can expand access to less complicated
primary cases and is an important addition to the continuum of care
for end-stage ankle arthritis patients.
- INBONE® II TAR System – Several product line
extensions for the INBONE® II TAR system will be featured,
including the availability of a smaller size talar dome to address
patients with small anatomy who would benefit from a smaller talar
dome option as well as a revision poly insert and uncoated tibia
stems to provide surgeons with more options.
- PROPHECY® Pre-Operative Navigation Alignment Guides
– Designed for use with the Company's INFINITY® and
INBONE® TAR Systems, the PROPHECY® Pre-Operative Navigation
Alignment Technology utilizes computed tomography (CT) scans to
create patient-specific ankle alignment guides that facilitate the
surgeons' ability to precisely size, place and align the INFINITY®
and INBONE® TAR components during surgery.
- ORTHOLOC® 3Di Flatfoot Plates – Designed to
increase the speed and accuracy of complex flatfoot procedures, the
ORTHOLOC® 3Di flatfoot system is a comprehensive flatfoot osteotomy
solution that features innovative 3Di medial displacement calcaneal
osteotomy plating technology.
Wright also announced that it received 510(k) clearance from the
U.S. Food and Drug Administration (FDA) to market the SALVATION™
External Fixation System. The SALVATION™ External Fixation System
is an integral part of Wright's SALVATION™ Limb Salvage product
portfolio, which includes the SALVATION™ Beaming System and the
SALVATION™ 3Di Plating System. Together, this comprehensive
portfolio of products is designed to address fractures, nonunions
and complex foot and ankle deformities and is the first complete
portfolio of products to be specifically indicated for use to treat
neuropathic osteoarthropathy (commonly referred to as Charcot
foot), a deformity (most commonly mid-foot collapse) that results
from nerve damage in the foot or ankle. Wright expects to initiate
limited physician testing of the SALVATION™ External Fixation
System to collect market assessment data in the second quarter of
2015.
Robert Palmisano, president and chief executive officer,
commented, "We have continued to expand our broad product portfolio
to further extend our leadership position in foot and ankle. The
INFINITY ankle's lower profile design and straightforward surgical
approach expands our access to less complicated primary cases and
continues to be an important catalyst in the ongoing market
conversion from fusion procedures to total ankle replacement. In
addition, we have a unique future opportunity to address advanced
reconstructive, limb salvage, and Charcot cases with our SALVATION
product portfolio. Despite the large and growing population at
high-risk of peripheral neuropathies, the Charcot market remains
underserved in terms of a comprehensive solution. We are looking
forward to collecting initial physician testing and market
assessment data for our SALVATION product portfolio in preparation
for a future product launch."
More information on Wright Medical's foot and ankle products can
be found at www.wmt.com/footandankle/. Wright is the exclusive
sponsor of WebMD's patient education section on total ankle
replacement, which can be accessed at
www.webmd.com/osteoarthritis/ankle-replacement-15.
About Wright Medical
Wright Medical Group, Inc. is a specialty orthopaedic company
that provides extremity and biologic solutions that enable
clinicians to alleviate pain and restore their patients'
lifestyles. The company is the recognized leader of surgical
solutions for the foot and ankle market, one of the fastest growing
segments in medical technology, and markets its products in over 60
countries worldwide. For more information about Wright
Medical, visit www.wmt.com.
Cautionary Note Regarding Forward-Looking
Statements
This press release includes forward-looking
statements. These forward-looking statements generally can be
identified by the use of words such as "anticipate," "expect,"
"plan," "could," "may," "will," "believe," "estimate," "forecast,"
"goal," "project," and other words of similar
meaning. Forward-looking statements in this press release
include, but are not limited to, statements about the potential for
market acceptance and clinical performance of our
products. Each forward-looking statement contained in this
press release is subject to risks and uncertainties that could
cause actual results to differ materially from those expressed or
implied by such statement. Applicable risks and uncertainties
include, among others, the risk that competitive products achieve
greater clinical success or market acceptance than our products, or
that our products, for whatever reason, are less successful or
clinically effective than presently anticipated, and the risks
identified under the heading "Risk Factors" in Wright's Annual
Report on Form 10-K, filed with the SEC on February 26, 2015, as
supplemented by our subsequent Quarterly Reports on Form 10-Q and
other information filed with the SEC. Investors should not
place considerable reliance on the forward-looking statements
contained in this press release. You are encouraged to read
Wright's filings with the SEC, available at www.sec.gov, for a
discussion of these and other risks and uncertainties. The
forward-looking statements in this press release speak only as of
the date of this release, and Wright undertakes no obligation to
update or revise any of these statements. Wright's business is
subject to substantial risks and uncertainties, including those
referenced above. Investors, potential investors, and others
should give careful consideration to these risks and
uncertainties.
CONTACT: Investors & Media:
Julie D. Tracy
Sr. Vice President, Chief Communications Officer
Wright Medical Group, Inc.
(901) 290-5817
julie.tracy@wmt.com
Wright Medical Group NV (NASDAQ:WMGI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Wright Medical Group NV (NASDAQ:WMGI)
Historical Stock Chart
From Apr 2023 to Apr 2024